Tyrosine receptor kinase B silencing inhibits anoikis-resistance and improves anticancer efficiency of sorafenib in human renal cancer cells

Peng Zhang(Huazhong University of Science and Technology), Yifei Xing(Union Hospital)
International Journal of Oncology
January 25, 2016
Cited by 32


Related Papers